delta Opioid R/OPRD1 Antibody Summary
Synthetic 15 amino acid peptide from C-terminus of human Delta Opioid Receptor.
Multi pass membrane protein
Human Delta Opioid Receptor. BLAST analysis of the peptide immunogen showed no homology with other human proteins.
Porcine (93%), Bovine (93%), Guinea Pig (93%), Rabbit (93%), Monkey (93%), Primate (93%). Backed by our 100% Guarantee.
IgG
Polyclonal
Rabbit
OPRD1
Immunogen affinity purified
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
Applications/Dilutions
- Immunohistochemistry-Paraffin 1:10 – 1:500
Reactivity Notes
Predicted cross-reactivity based on sequence identity: Chimpanzee (93%), Gorilla (93%), Orangutan (93%), Galago (93%), Marmoset (93%), Rat (86%).
Packaging, Storage & Formulations
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
PBS
0.1% Sodium Azide
1.0 mg/ml
Immunogen affinity purified
Alternate Names for delta Opioid R/OPRD1 Antibody
- delta Opioid R
- delta opioid receptor 1
- delta-type opioid receptor
- DOP
- dOpioidR
- DOR1
- D-OR-1
- DOR-1
- OP1
- opioid receptor, delta 1
- OPRD
- OPRD1
Background
OPRD1 is an Opioid Receptor that is involved in the control of anxiety, depression, and pain. It is a promising target in the therapy of mood-altering disorders and drug addiction. Delta and kappa opioid receptors function synergistically by forming heterodimers. OPRD1 expression has been reported primarily in the brain. High OPRD1 expression has been documented in the cortex, caudate, hippocampus, nucleus accumbens, and putamen; low OPRD1 expression has been identified in the cerebellum, hypothalamus, substantia nigra, and thalamus. OPRD1 expression is reduced in the putamen and amygdala of Alzheimers patients and in the putamen in Parkinsons disease.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.